Literature DB >> 14623800

Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.

Josep Brugada1, Ramon Brugada, Pedro Brugada.   

Abstract

BACKGROUND: Patients with Brugada syndrome who were resuscitated from an episode of ventricular fibrillation are at high risk for recurrent sudden death. There is general agreement about the therapeutic strategy for these patients. Conversely, the prognosis and approach in patients with a diagnostic ECG but without a previous history of sudden cardiac death is controversial. We analyzed a large cohort of patients with Brugada syndrome without previous cardiac arrest to understand the determinants of prognosis. METHODS AND
RESULTS: A total of 547 patients with an ECG diagnostic of Brugada syndrome and no previous cardiac arrest were studied. The mean age was 41+/-15 years, and 408 were male. The diagnostic ECG was present spontaneously in 391 patients. In the remaining 156 individuals, the abnormal ECG was noted only after the administration of an antiarrhythmic drug. One hundred twenty-four patients had suffered from at least 1 episode of syncope. During programmed ventricular stimulation, a sustained ventricular arrhythmia was induced in 163 of 408 patients. During a mean follow-up of 24+/-32 months, 45 patients (8%) suffered sudden death or documented ventricular fibrillation. Multivariate analysis identified the inducibility of a sustained ventricular arrhythmia (P<0.0001) and a history of syncope (P<0.01) as predictors of events. Logistic regression analysis showed that a patient with a spontaneously abnormal ECG, a previous history of syncope, and inducible sustained ventricular arrhythmias had a probability of 27.2% of suffering an event during follow-up.
CONCLUSIONS: Individuals with Brugada syndrome and no previous cardiac arrest have a high risk of sudden death. Inducibility of ventricular arrhythmias and a previous history of syncope are markers of a poor prognosis.

Entities:  

Mesh:

Year:  2003        PMID: 14623800     DOI: 10.1161/01.CIR.0000104568.13957.4F

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  87 in total

1.  Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.

Authors:  Christian Wolpert; Constanze Echternach; Christian Veltmann; Charles Antzelevitch; George P Thomas; Susanne Spehl; Florian Streitner; Juergen Kuschyk; Rainer Schimpf; Karl K Haase; Martin Borggrefe
Journal:  Heart Rhythm       Date:  2005-03       Impact factor: 6.343

Review 2.  Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2005-05-25       Impact factor: 4.164

3.  Risk stratification in Brugada syndrome.

Authors:  Kathryn A Glatter; Nipavan Chiamvimonvat; Matti Viitasalo; Qing Wang; Dipika Tuteja
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

4.  Syncope due to Brugada syndrome in a young athlete.

Authors:  Hans D Esperer; Olaf Hoos; Kuno Hottenrott
Journal:  Br J Sports Med       Date:  2006-11-30       Impact factor: 13.800

5.  Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.

Authors:  Sandeep Joshi; Farbod Raiszadeh; Walter Pierce; Jonathan S Steinberg
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

6.  [Brugada syndrome].

Authors:  Christian Wolpert; Claudia Herrera-Siklody; Ulli Parade; Christian Strotmann; Norman Rüb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-12

7.  For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death.

Authors:  Ivaylo Tonchev; David Luria; David Orenstein; Chaim Lotan; Yitschak Biton
Journal:  Curr Cardiol Rep       Date:  2019-08-02       Impact factor: 2.931

Review 8.  [Right ventricular arrhythmias].

Authors:  T Wichter; M Paul; L Eckardt; G Breithardt
Journal:  Internist (Berl)       Date:  2004-10       Impact factor: 0.743

Review 9.  Pathogenesis and management of Brugada syndrome.

Authors:  Juan Sieira; Gregory Dendramis; Pedro Brugada
Journal:  Nat Rev Cardiol       Date:  2016-09-15       Impact factor: 32.419

10.  Current Management of Syncope: Treatment Alternatives.

Authors:  Carlos A. Morillo; Adrián Baranchuk
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.